Corcept Therapeutics Incorporated (CORT)
Payables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 10,882 | 9,803 | 8,581 | 7,631 | 6,482 | 6,085 | 5,779 | 5,521 | 5,385 | 5,259 | 5,195 | 5,263 | 5,281 | 5,181 | 5,122 | 4,972 | 5,582 | 5,764 | 5,999 | 6,142 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $10,882K ÷ $—K
= —
The payables turnover ratio for Corcept Therapeutics Incorporated is not available as the data for accounts payable turnover is not provided in the financial statements for the periods up to December 31, 2024. The payables turnover ratio measures how efficiently a company is managing its payments to suppliers and creditors. A higher payables turnover ratio typically indicates that the company is paying its suppliers more quickly, which may signal strong liquidity or effective working capital management. On the other hand, a lower payables turnover ratio could indicate that the company is taking longer to pay its bills, which may suggest liquidity issues or challenges in managing vendor relationships. Without the specific data on payables turnover for Corcept Therapeutics, a detailed analysis of this ratio's trends and implications for the company's financial health and operational efficiency cannot be provided.
Peer comparison
Dec 31, 2024